Clinical trial
Dexmedetomidine Versus Dexamethasone Adding to Ondansetron for Prophylaxis Against Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
NCT06017167 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexmedetomidine Versus Dexamethasone Adding to Ondansetron for Prophylaxis Against Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
- Lead sponsor
- Tanta University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 15, 2022
- Completion date
- October 31, 2023
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
laparoscopic cholecystectomy, postoperative nausea and vomiting